LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Patterns of discontinuation in patients with IPF treated with open-label nintedanib: data from INPULSIS-ON

Photo from archive.org

INPULSIS®-ON Ulrich Costabel,1 Michael Kreuter,2 Jin Woo Song,3 John T Huggins,4 Benoit Wallaert,5 Wibke Stansen,6 Susanne Stowasser,6 Manuel Quaresma,6 Bruno Crestani7 1Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, Germany; 2Center… Click to show full abstract

INPULSIS®-ON Ulrich Costabel,1 Michael Kreuter,2 Jin Woo Song,3 John T Huggins,4 Benoit Wallaert,5 Wibke Stansen,6 Susanne Stowasser,6 Manuel Quaresma,6 Bruno Crestani7 1Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, Germany; 2Center for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Germany; 3ASAN Medical Center, Seoul, South Korea; 4Medical University of South Carolina, Charleston, South Carolina, USA; 5University Hospital of Lille, Lille, France; 6Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; 7APHP, Hôpital Bichat, Service de Pneumologie A, DHU FIRE; INSERM, Unité 1152; Université Paris Diderot, Paris, France.

Keywords: ipf treated; patterns discontinuation; patients ipf; university; discontinuation patients; inpulsis

Journal Title: European Respiratory Journal
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.